Mark Abie Horowitz
Overview
Explore the profile of Mark Abie Horowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siddiqui F, Petersen J, Juul S, Kamp C, Barbateskovic M, Moncrieff J, et al.
BMJ Open
. 2025 Feb;
15(2):e082853.
PMID: 39920066
Objectives: To assess the beneficial and harmful effects of duloxetine versus 'active placebo', placebo or no intervention for adults with major depressive disorder. Design: Systematic review with meta-analysis and trial...
2.
Kamp C, Petersen J, Faltermeier P, Juul S, Sillassen C, Siddiqui F, et al.
BMC Psychiatry
. 2025 Jan;
25(1):67.
PMID: 39844067
Background: Mirtazapine is used to treat depression worldwide, and the effects of mirtazapine on depression rating scales are well-known. Our primary objective was to assess the risks of adverse events...
3.
Horowitz M, Taylor D
Australas Psychiatry
. 2024 Dec;
:10398562241308437.
PMID: 39711136
No abstract available.
4.
Zhang M, Tan X, Zheng Y, Zeng N, Li Z, Horowitz M, et al.
Mol Psychiatry
. 2024 Oct;
PMID: 39394455
Antidepressants are among the most extensively prescribed psychotropic drugs worldwide. Discontinuation induced withdrawal symptoms have been reported for almost all antidepressants. The incidence of antidepressant withdrawal syndrome (AWS) and other...
5.
Kamp C, Petersen J, Faltermeier P, Juul S, Siddiqui F, Barbateskovic M, et al.
BMJ Ment Health
. 2024 Aug;
27(1.
PMID: 39093721
Question: Tricyclic antidepressants are used to treat depression worldwide, but the adverse effects have not been systematically assessed. Our objective was to assess the beneficial and harmful effects of all...
6.
7.
Jorgensen C, Juul S, Siddiqui F, Horowitz M, Moncrieff J, Munkholm K, et al.
Syst Rev
. 2023 Mar;
12(1):57.
PMID: 36991504
Background: Major depressive disorder causes a great burden on patients and societies. Venlafaxine and mirtazapine are commonly prescribed as second-line treatment for patients with major depressive disorder worldwide. Previous systematic...
8.
Read J, Moncrieff J, Horowitz M
J Psychiatr Res
. 2023 Mar;
161:298-306.
PMID: 36989904
Background: Public Health England has recommended that services be put in place to support people who choose to withdraw from antidepressants because of a current gap. This study aims to...
9.
Horowitz M, Framer A, Hengartner M, Sorensen A, Taylor D
CNS Drugs
. 2022 Dec;
37(2):143-157.
PMID: 36513909
Adaptation of the brain to the presence of a drug predicts withdrawal on cessation. The outcome of adaptation is often referred to as 'physical dependence' in pharmacology, as distinct from...
10.
Munkholm K, Horowitz M, Moncrieff J
Lancet
. 2022 Sep;
400(10357):995.
PMID: 36154688
No abstract available.